<![CDATA[Proton Therapy Does Not Improve Survival in Hepatocellular Carcinoma]]>

Phase 3negativeProton TherapyNegative

AI Analysis

Summary

The phase 3 NRG-GI003 trial demonstrated that proton therapy provided no overall survival benefit compared to photon therapy in patients with advanced hepatocellular carcinoma, representing a negative outcome for this treatment approach.

Clinical Trial Data

Phase

Phase 3

Primary Endpoint

Not Met

Outcome Details

Proton therapy showed no overall survival benefit over photon therapy in advanced hepatocellular carcinoma

Importance:6/10

Sentiment:

-0.60

hepatocellular carcinomaproton therapyclinical trialoncologynegative outcome

Read the original article

Published by Cancer Network on September 29, 2026 4:00 PM

Read Original